BIOTIE THERAPIES CORP SPONSORED ADR
BITI
BITI was delisted on the 10th of June, 2016.
15 hedge funds and large institutions have $54.7M invested in BIOTIE THERAPIES CORP SPONSORED ADR in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
13% more capital invested
Capital invested by funds: $48.6M → $54.7M (+$6.11M)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.12M |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
+$1.94M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.74M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$146K |
| 5 |
Citigroup
New York
|
+$70K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$2.87M |
| 2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$1.06M |
| 3 |
Morgan Stanley
New York
|
-$75.7K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$44.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$19K |
BITI Hedge Fund Activity: Q4 2015 in Review
15 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in BIOTIE THERAPIES CORP SPONSORED ADR (BITI) for Q4 2015, worth a combined $54.7M — up 13% from $48.6M a quarter earlier.
Fund positioning in BITI was balanced in Q4 2015: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $2.12M. The largest seller was Deerfield Management, exiting entirely with an estimated $2.87M sold.
- 15 institutional investors held BIOTIE THERAPIES CORP SPONSORED ADR (BITI) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $54.7M of BIOTIE THERAPIES CORP SPONSORED ADR stock for Q4 2015, up 13% quarter-over-quarter.
- 3 funds opened new BIOTIE THERAPIES CORP SPONSORED ADR positions in Q4 2015 and 3 closed out, a net change of 0 holders.
- The largest BIOTIE THERAPIES CORP SPONSORED ADR buyer in Q4 2015 was Fidelity Investments, an estimated $2.12M added.
- The largest BIOTIE THERAPIES CORP SPONSORED ADR seller in Q4 2015 was Deerfield Management, an estimated $2.87M sold.
Based on aggregated 13F filings for Q4 2015.